← Back to Clinical Trials
Recruiting NCT05683405

NCT05683405 Management of Peri-implantitis: Non-surgical Treatment of Peri-implantitis.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05683405
Status Recruiting
Phase —
Sponsor Tannhelsetjenestens Kompetansesenter for Nord-Norge
Condition Peri-Implantitis
Study Type INTERVENTIONAL
Enrollment 88 participants
Start Date 2023-08-01
Primary Completion 2026-08

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 85 Years
Study Type INTERVENTIONAL
Interventions
Non-surgical treatment of peri-implantitis with mechanical debridementNon-surgical treatment of peri-implantitis with air polishing

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 88 participants in total. It began in 2023-08-01 with a primary completion date of 2026-08.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to compare non-surgical treatment by mechanical debridement with air-polishing in peri-implantitis. The main question it aims to answer is: • Does non-surgical treatment of peri-implantitis with an air-polishing devise (Perioflow® EMS, Nyon Switzerlad) provide a better treatment result than conventional cleaning with mechanical instruments? Participants will receive non-surgical treatment of peri-implantitis either with mechanical debridement and with an air-polishing devise. Researchers will compare pocket depth and bleeding/suppuration on probing in implants treated with the two methods to see if either of them is more efficient in treatment of peri-implantitis.

Eligibility Criteria

Inclusion Criteria: * Referred to TkNN (Tannhelsetjenestens kompetansesenter for Nord-Norge) for treatment of peri-implantitis * Participants should have at least one implants with peri-implantitis according to the diagnostic criteria from the 2017 Chicago Consensus Meeting. Exclusion Criteria: * Cemented prosthetic reconstructions, individuals smoking more than 10 cigarettes per day, individuals with diabetes and poor control of blood glucose levels, antibiotic treatment during the past threee months, and implants that are preferably to be extracted due to prognosis or function, are excluded.

Contact & Investigator

Central Contact

Elin Hadler-Olsen, PhD

✉ elin.hadlerolsen@tffk.no

📞 +47 48 06 72 49

Frequently Asked Questions

Who can join the NCT05683405 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Peri-Implantitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05683405 currently recruiting?

Yes, NCT05683405 is actively recruiting participants. Contact the research team at elin.hadlerolsen@tffk.no for enrollment information.

Where is the NCT05683405 trial being conducted?

This trial is being conducted at Tromsø, Norway.

Who is sponsoring the NCT05683405 clinical trial?

NCT05683405 is sponsored by Tannhelsetjenestens Kompetansesenter for Nord-Norge. The trial plans to enroll 88 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology